Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Clinical trial NCT04938583 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04938583
Sponsor: CanariaBio Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer by FIGO Stage Ovarian Cancer Stage III Ovarian Cancer Stage IV

Start date: 2021-03-17
Primary completion: 2025-10-30
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.